Institut de Cancerologie Strasbourg Europe Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04378920
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Institut de Cancerologie Strasbourg Europe | Institut de cancérologie Strasbourg Europe